跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
希笛尼 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Cinitapride Hydrogen Tartrate Tablets
Approved
化学药品
Cinitapride Hydrogen Tartrate Tablets
ALMIRALL SA
🇨🇳 National Medical Products Administration
Approval Date
Feb 25, 2020
Approval ID
7MazXcS9iKm
Company
ALMIRALL SA
Type
化学药品
Approval Details
Approval Id
7MazXcS9iKm
Approval Number
H20170099
Generic Name
酒石酸西尼必利片
Generic Name En
Cinitapride Hydrogen Tartrate Tablets
Trade Name
希笛尼
Drug Type
化学药品
Dosage Form
片剂
Strength
1mg(按西尼必利计)
Reg Date
2020-02-25
Expired Date
2025-02-24
Company Name
ALMIRALL SA
Company Address
Ronda General Mitre, 151 08022 BARCELONA SPAIN
Production Company Name
industrias farmacéuticas almirall, s. a.
Production Company Address
Ctra.de Martorell,41-61-08740 Sant Andreu de la Barca-Barcelona (Spain)
Company Detail Path
/organization/almirall-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 25, 2020
Approval ID
7MazXcS9iKm
Type
化学药品
Back to NMPA Approvals